Sharma Vineeta, Witkowski Andrzej, Witkowska H Ewa, Dykstra Andrew, Simonsen Jens B, Nelbach Lisa, Beckstead Jennifer A, Pullinger Clive R, Kane John P, Malloy Mary J, Watson Gordon, Forte Trudy M, Ryan Robert O
From the Children's Hospital Oakland Research Institute, CA (V.S., A.W., J.B.S., L.N., J.A.B., G.W., T.M.F., R.O.R.); Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF Sandler-Moore Mass Spectrometry Core Facility, San Francisco, CA (H.E.W., A.D.); and Cardiovascular Research Institute, University of California, San Francisco (C.R.P., J.P.K., M.J.M.).
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2254-60. doi: 10.1161/ATVBAHA.114.304027. Epub 2014 Aug 14.
Apolipoprotein A-V (apoA-V) is a low-abundance plasma protein that modulates triacylglycerol homeostasis. Gene transfer studies were undertaken in apoa5 (-/-) mice to define the mechanism underlying the correlation between the single-nucleotide polymorphism c.553G>T in APOA5 and hypertriglyceridemia.
Adeno-associated virus (AAV) 2/8-mediated gene transfer of wild-type apoA-V induced a dramatic lowering of plasma triacylglycerol in apoa5 (-/-) mice, whereas AAV2/8-Gly162Cys apoA-V (corresponding to the c.553G>T single-nucleotide polymorphism: rs2075291; p.Gly185Cys when numbering includes signal sequence) had a modest effect. Characterization studies revealed that plasma levels of wild-type and G162C apoA-V in transduced mice were similar and within the physiological range. Fractionation of plasma from mice transduced with AAV2/8-G162C apoA-V indicated that, unlike wild-type apoA-V, >50% of G162C apoA-V was recovered in the lipoprotein-free fraction. Nonreducing SDS-PAGE immunoblot analysis provided evidence that G162C apoA-V present in the lipoprotein-free fraction, but not that portion associated with lipoproteins, displayed altered electrophoretic mobility consistent with disulfide-linked heterodimer formation. Immunoprecipitation followed by liquid chromatography/mass spectrometry of human plasma from subjects homozygous for wild-type APOA5 and c.553G>T APOA5 revealed that G162C apoA-V forms adducts with extraneous plasma proteins including fibronectin, kininogen-1, and others.
Substitution of Cys for Gly at position 162 of mature apoA-V introduces a free cysteine that forms disulfide bonds with plasma proteins such that its lipoprotein-binding and triacylglycerol-modulation functions are compromised.
载脂蛋白A-V(apoA-V)是一种低丰度血浆蛋白,可调节三酰甘油稳态。在载脂蛋白A5基因敲除(apoa5(-/-))小鼠中进行基因转移研究,以确定APOA5基因中c.553G>T单核苷酸多态性与高甘油三酯血症之间相关性的潜在机制。
腺相关病毒(AAV)2/8介导的野生型apoA-V基因转移可使apoa5(-/-)小鼠的血浆甘油三酯显著降低,而AAV2/8-Gly162Cys apoA-V(对应于c.553G>T单核苷酸多态性:rs2075291;编号包括信号序列时为p.Gly185Cys)的作用则较为适度。特性研究表明,转导小鼠中野生型和G162C apoA-V的血浆水平相似且在生理范围内。对用AAV2/8-G162C apoA-V转导的小鼠血浆进行分级分离表明,与野生型apoA-V不同,超过50%的G162C apoA-V在无脂蛋白部分中被回收。非还原SDS-PAGE免疫印迹分析提供的证据表明,无脂蛋白部分中的G162C apoA-V,而非与脂蛋白相关的部分,显示出与二硫键连接的异二聚体形成一致的电泳迁移率改变。对野生型APOA5和c.553G>T APOA5纯合子受试者的人血浆进行免疫沉淀,随后进行液相色谱/质谱分析,结果显示G162C apoA-V与包括纤连蛋白、激肽原-1等在内的外来血浆蛋白形成加合物。
成熟apoA-V第162位的甘氨酸被半胱氨酸取代会引入一个游离半胱氨酸,该半胱氨酸与血浆蛋白形成二硫键,从而损害其脂蛋白结合和三酰甘油调节功能。